Watermark

Advancing Global Health

Scientist preparing a sample for cancer therapy treatment, a key step in treating cancer effectively.

Our Unique Approach

Our expansive internal resources and capabilities enhance our control over quality, speed, cost, and risk—key factors in delivering innovative, safe, and accessible therapies to patients worldwide.

We are able to accelerate clinical trials due to our extensive geographic reach and our ability to share expertise and insights with markets across the globe. Our business is structured to broaden global access through the following strategic cost and time advantages:

  • In-house R&D and manufacturing enable speed and cost efficiencies with better oversight to ensure that our high standards are met.
  • Our global footprint supports local expertise, broad participation in trials, expedited regulatory approvals, and operational resilience.
  • Strategic partnerships help us overcome barriers and reach patients in underserved communities.
  • Our fast-to-Proof of Concept (PoC) strategy that has been shown to deliver molecules to the clinic with industry leading speed.

Upholding our value of Patients First, our Global Patient Safety team ensures the safe and effective use of our medicines from their first use in clinical trials to prescribed post-commercialization use.

For more information about our Science, please visit Medicines, Research & Development, and Pipeline.

Our Commitment to Access

Our vision is to transform the biotechnology industry, creating impactful medicines that will be accessible to more cancer patients around the world. Our global strategy to achieve this includes:

Commercial Reach

Expanding our commercial presence and distribution infrastructure in established and growing markets.

Accessibility

We work closely with healthcare systems, regulators, payers, and partners to remove barriers and accelerate access while navigating diverse and evolving regulatory and reimbursement requirements across jurisdictions.

Support

Developing assistance programs, which include low- or no-cost medicines to eligible patients, where permissible.

For more information, read about our Expanded Access Programs and Patient Support Program.

Patient Engagement & Advocacy

We seek to ensure that our approach to drug development and commercialization accurately reflects patients’ true lived experiences and expectations—a central component of providing patients with meaningful treatment. Actively engaging with patients throughout clinical development ensures our therapies meet patient needs, which ultimately supports better outcomes.

Our strategies for global patient advocacy vary based on local healthcare systems, but in all regions we seek to identify and address barriers to treatment access. A crucial component of our success lies in ensuring the independence of patient organizations. These commitments are detailed in our Global Policy Position on Partnering with Patient Organizations.

For more information about our campaigns, please visit Cancer & Mental Health.